` 002923 (Zhuhai Rundu Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

002923
vs
S
Shanghai Composite

Over the past 12 months, Zhuhai Rundu Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of -9% compared to the Shanghai Composite's +27% growth.

Stocks Performance
002923 vs Shanghai Composite

Loading
002923
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
002923 vs Shanghai Composite

Loading
002923
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
002923 vs Shanghai Composite

Loading
002923
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Zhuhai Rundu Pharmaceutical Co Ltd vs Peers

Shanghai Composite
002923
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Zhuhai Rundu Pharmaceutical Co Ltd
Glance View

Market Cap
4.4B CNY
Industry
Pharmaceuticals

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the manufacture, research and development, and marketing of pharmaceutical drugs. The company is headquartered in Zhuhai, Guangdong and currently employs 1,594 full-time employees. The company went IPO on 2018-01-05. The Company’s products cover the fields of cardio-cerebral blood vessels, digestion and anesthesia, among others.

Intrinsic Value
8.11 CNY
Overvaluation 38%
Intrinsic Value
Price ¥13.09
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett